Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K reports on the Annual General Meeting of Shareholders held by Entera Bio Ltd. on September 27, 2018. The filing details the outcomes of shareholder votes regarding corporate governance, auditor appointment, and director elections.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document notes that the Company's financial statements for the year ended December 31, 2017, were discussed at the meeting, but no numerical data from those statements is included in this report.
Material Changes
No material financial changes versus prior periods are reported in this document. The filing focuses exclusively on the results of the shareholder vote.
Corporate Actions and Governance
- Auditor Appointment: Shareholders approved the appointment of Kesselman & Kesselman (PwC Israel) as the independent registered public accounting firm for the fiscal year ending December 31, 2018.
- Director Elections:
- Re-elected Mr. Zeev Bronfeld and Dr. Roger Garceau as Class I directors until the 2021 annual meeting.
- Elected Ms. Faith L. Charles and Ms. Miranda J. Toledano as external directors for a three-year term commencing September 27, 2018.
- Compensation Policy: Shareholders approved the Company's Directors and Officers Compensation Policy.
Key Facts for Investor Verification
- Verify the full text of the Directors and Officers Compensation Policy approved at the meeting.
- Review the financial statements for the year ended December 31, 2017, referenced in the meeting but not detailed in this filing.
- Confirm the terms of engagement and compensation for the newly appointed auditor, Kesselman & Kesselman.
- Check the Company's proxy statement (Exhibit 99.1) for detailed background on the six proposals voted upon.